Skip to main content

Closed

VERA: Vera Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-66.5%

Financially safe

Stretched

Debt / equity0.15×

Interest coverage-34.0×

Current ratio13.64×

Vera Therapeutics, Inc.

VERANASDAQ Global Market·USD·Closed

Vera Therapeutics, Inc.

VERANASDAQ·USD·Closed

$32.10

−2.87%

$32.10

−$0.95 (2.87%)

52W Range

35thpctl

Volume

0.83×avg

Mkt Cap

2.30BUSD

P/E

-5.8TTM

Div Yield

–ann

52W Range

35thpctl

Volume

0.83×avg

Market Cap

2.30BUSD

P/E Ratio

-5.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings